Diamond Sponsors | | |
| Otsuka Pharmaceutical | |  |
| | | |
Vera Therapeutics is a late clinical-stage biotechnology company focused on developing treatments for serious immunological diseases in order to change the standard of care for patients. Our lead investigational therapy is atacicept, a fusion protein self-administered at home as a subcutaneous once weekly injection that blocks both B-cell Activating Factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), which stimulate B cells to produce autoantibodies contributing to certain autoimmune diseases, including immunoglobulin A nephropathy (IgAN) and lupus nephritis. Beyond IgAN, Vera Therapeutics is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove clinically meaningful. In addition, Vera Therapeutics holds an exclusive license agreement with Stanford University for a novel, next generation fusion protein targeting BAFF and APRIL, known as VT-109, with wide therapeutic potential across the spectrum of B-cell-mediated diseases. Vera Therapeutics is also developing MAU868, a monoclonal antibody designed to neutralize infection with BK virus, which can have devastating consequences in kidney transplant recipients. Vera Therapeutics retains all global developmental and commercial rights to atacicept, VT-109 and MAU868 | |  |
| | | |
Platinum Sponsor | | |
| Amgen | |  |
| | | |
| Bayer's legacy in cardiovascular care spans decades of scientific innovation and patient-focused research. As a long-standing leader in cardiology, Bayer has consistently advanced therapies that address the complex interplay between the heart and kidneys—two organs deeply connected in both health and disease. Today, that heritage continues to guide our commitment to developing innovative treatments for patients facing high unmet medical needs. With a growing portfolio of approved therapies and promising compounds in development, Bayer is shaping the future of cardiovascular care through precision medicine, scientific rigor, and a deep sense of purpose. | |  |
| | | |
| At Travere Therapeutics we are in rare for life. We come together every day to help patients, families and caregivers as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent and we work with the rare disease community to identify, develop and deliver life-changing therapies. We continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. | |  |
| | | |
Gold Sponsor | | |
| Ardelyx is a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. | |  |
| | | |
Silver Sponsor | | |
| Alnylam Pharmaceuticals | | |
| | | |
| Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first and only therapy for geographic atrophy, a leading cause of blindness around the world. With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases. | |  |
| | | |
Mallinckrodt is a leading provider of life-enhancing therapeutics focused on addressing unmet patient needs in the areas of autoimmune and rare diseases, including endocrinology, gastroenterology, hepatology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology, and urology. To learn more, visit www.MNK-Endo.com. | |  |
| | | |
| Novartis | | |
| | | |
Bronze Sponsor
|
|
|
| Alexion | | |
| | | |
| ANI Pharmaceuticals | | |
| | | |
Aurinia is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. In January 2021, the Company introduced LUPKYNIS® (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. Aurinia is also developing Aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) for the potential treatment of autoimmune diseases. Please visit https://www.auriniapharma.com/ to learn more.
| |  |
| | | |
| Calliditas Therapeutics | | |
| | | |
| CareDx aspires to achieve its vision — a world where every patient receives the transplant they need to live longer, fuller lives. We are driven by our mission to create life-changing solutions that enable transplant patients to thrive. | |  |
| | | |
| Central Florida Kidney Centers (CFKC) is an independent, non-profit dialysis organization dedicated to delivering compassionate care to the kidney community for over 53 years. We provide a full range of services—including in-center dialysis, peritoneal dialysis, and home hemodialysis—for both adult and pediatric patients. Guided by our commitment to quality and personalized care, CFKC proudly lives by the motto: “Large enough to serve. Small enough to care. | |  |
| | | |
| At CorMedix Therapeutics, we’re driven to protect vulnerable patients from serious, life-threatening infections. With eight commercial-stage products spanning prevention and treatment, we address critical, unmet needs across multiple care settings. Our dedicated team is committed to ensuring access to our therapies and to continuously expanding our portfolio to improve patient outcomes. | |  |
| | | |
| Eurofins Transplant Genomics Meeting the needs of transplant patients and providers is a challenge unlike another. From pre- to post-transplant, we’re equipped with testing solutions that can do just that. Eurofins Transplant Genomics and Eurofins Ascend come together to provide testing solutions for all stages of the transplant journey. | |  |
| | | |
Fresenius Medical Care North America We Help Make Dialysis Care Happen.
When you partner with Fresenius Medical Care (FME), you get 30-plus years of renal therapies expertise. You get a product portfolio that covers nearly every aspect of dialysis care and many of the most recognized product names in the industry. You get exceptional customer service and a truly reliable supply chain. In short, you get what you need when you need it, so your patients can too.
| |  |
| | | |
| Genentech pioneered the biotech industry, combining rigorous science with cutting-edge technology in a way never seen before – and that same spirit of disrupting the status quo and setting new standards continues to fuel us as we pursue the medicines of tomorrow. | |  |
| | | |
| MedPro | | |
| | | |
DNA is in our blood
Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized
genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives.
|
|
 |
| |
|
|
| Novo Nordisk |
|
|
| | | |
| OPKO Renal | | |
| | | |
| Practice Pays | | |
| | | |
| Risk Strategies | | |
| | | |
| | | |
EXHIBITORS
|
|
|
| Advanta Biometrics is a full-service / turnkey CMS ancillary services partner. We help you launch a successful Chronic Care Management program by providing care managers who act as extensions of your practice to engage Medicare / Medicare Advantage patients in meaningful conversations, improving outcomes for them and driving revenue for your practice. | |  |
| | | |
Akebia Therapeutics Therapeutics is a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. We leverage scientific expertise and commercial capabilities to deliver unique therapeutics to address the complications of kidney disease. We are dedicated to working with our partners, patients, advocacy organizations, and the broader kidney community. | |  |
| | | |
| Amicus Therapeutics | | |
| | | |
| Arkana Laboratories | | |
| | | |
| Ascend Clinical delivers advanced renal diagnostics that support the full continuum of care, from early CKD detection and dialysis testing to post-transplant monitoring. Our integrated testing, data analytics, and partnerships enable nephrologists and care teams to improve outcomes, streamline workflows and provide patients with precise and timely insights at every stage of kidney disease. | |  |
| | | |
| Azura Surgery Center - Plantation | | |
| | | |
| Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases. As a family business, Chiesi Group strives to create a world where it is common to have a therapy for all diseases and acts as a force for good, for society and the planet. | |  |
| | | |
| CSL Vifor | | |
| | | |
| Cycle Pharmaceuticals is strongly committed to providing quality treatment and services to patients with rare metabolic, immunological, oncological and neurological conditions. This is achieved through a patient-first approach and the use of the latest pharmaceutical technologies. Our focus is on delivering individualized support to patients, families, carers, and the healthcare professional community. At Cycle Pharmaceuticals, we believe that every patient matters. | |  |
| | | |
|
DaVita is a global leader in kidney care, delivering high-quality, innovative services for over 25 years. We support patients at every stage-from prevention, dialysis,
and transplant across all care settings. Our goals: improve outcomes, lower costs, and provide personalized care for patients, everywhere, fueled by a culture of compassion.
|
|
.png) |
| |
|
|
|
Fresenius Kidney Care is dedicated to achieving optimal sustainable clinical, quality and technological standards in patient care by providing high-quality,
personalized care, resources, and support. We help people with the physical and emotional challenges of kidney disease so they can lead meaningful and fulfilling lives on their own terms.
|
|
 |
| | | |
| GSK | | |
| |
|
|
| Innovative Renal Care (IRC) is a national leader in kidney care, partnering with nephrologists and health systems to provide exceptional care for patients with chronic
kidney disease and end-stage renal disease. Through joint ventures and an innovative, collaborative model, IRC empowers local care teams with the tools, technology, and support to deliver industry-leading clinical outcomes and a better
patient experience. Guided by our commitment to Delivering More Tomorrows, IRC stands apart as a trusted partner in advancing kidney care—one patient, one partnership, and one outcome at a time. To learn more, visit www.innovativerenal.com.
|
|
 |
| | | |
| Kyowa Kirin | | |
| | | |
| The Miami Transplant Institute (MTI) is a distinguished collaboration between the University of Miami Miller School of Medicine and Jackson Memorial Hospital. For over half a century, MTI has successfully performed nearly 10,000 kidney transplants, showcasing a long-standing legacy of excellence. MTI is one of the largest kidney transplant programs in Florida and stands as a national leader in providing life-saving kidney and pancreas transplant surgeries using robotic laparoscopic technology. Our expertise extends to highly complex and challenging transplant cases, and we are proud of our exceptional post-transplant outcomes. | |  |
| |
|
|
National Dialysis Accreditation Commission is the leading dialysis Accreditation Organization (AO) in the U.S. and was the first AO approved by CMS for deemed status
for ESRD. Dialysis providers successfully completing NDAC’s accreditation process may be awarded Medicare certification from CMS. NDAC provides accreditation in all 50 states and U.S. territories. Learn more about us at
www.ndacommission.com or contact us today at info@ndacommission.com.
|
|
 |
| | | |
| The National Kidney Foundation of Florida (NKFF) is a not-for-profit, 501(c)(3) voluntary health organization dedicated to kidney health and supporting people affected by kidney disease throughout the state. The NKFF focuses on local programs and services tailored to Floridians living with or at risk for kidney disease. NKFF works to support patients and educate the public on kidney health while providing programs that reduce the burden of kidney disease for affected individuals and their families. | |  |
| | | |
| NephCure’s mission is to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible. Founded in 2000 by a group of committed patient parents, NephCure has invested more than $40 million in kidney disease research and helped create a landscape where there are now new treatments and more than 60 interventional drug trials for rare kidney diseases. NephCure is a U.S. tax exempt 501(c)(3) public charity. | |  |
| | | |
| Nephro-Tech, Inc |
|
|
| | | |
| Neway, LLC | | |
| | | |
| N’Sync Consulting Corp | | |
| | | |
| Nuwellis is a medical technology company advancing precision fluid management across the cardio-renal continuum. The Aquadex® system delivers controlled ultrafiltration to safely remove excess fluid, supporting recovery, protecting organ function, and improving outcomes for patients in critical care, pediatrics, cardiac surgery, and hospital-based outpatient settings. | |  |
| | | |
| Outset is a medical technology company transforming the dialysis experience across the continuum of care with a first-of-its-kind technology. The Tablo® Hemodialysis System, FDA-cleared for use from hospital to home, is trusted by more than 1,000 U.S. healthcare facilities and has enabled millions of treatments delivered by thousands of nurses. | |  |
| | | |
Physician Software Systems – technology to meet the challenges dialysis providers are facing in 2025!
Providing AI-driven, individualized, ESA and iron dosing decision support to improve patient care, automation to streamline clinical tasks and improve efficiency, and operational oversight and assistance from senior team members to staff at individual units.
| |  |
| | | |
Renalytix - Our singular goal is to eradicate kidney disease. With our KidneyIntelX™ technology, we help clinical teams understand patient level of risk for progressive decline in kidney function in the earliest stages of diabetic kidney disease.
Knowing patient risk early enables clinicians to focus resources and guideline-recommended treatment accordingly, which provides the best chance for improving outcomes. | |  |
| | | |
| Renvio is a healthcare technology company dedicated exclusively to the dialysis industry, offering cloud-based solutions that unify clinical operations, billing, and analytics. With integrated AI for clinical risk prediction, automated charting, and enhanced support, Renvio empowers dialysis providers to deliver proactive, efficient care and improve outcomes—without disrupting workflows. | |  |
| | | |
Sanofi We are an R&D driven, AI-powered biopharmaceutical company committed to improving people’s lives and delivering compelling growth. | |  |
| | | |
| Takeda | | |
| | | |
| Tampa General Hospital (TGH) is a leading private, not-for-profit academic health system and one of Florida’s largest hospitals. Ranked #1 in Tampa Bay by U.S. News & World Report for 2025–26, TGH serves over 4 million residents and is nationally recognized in six specialties for world-class care. | |  |
| | | |
| The Florida Renal Association | | |
| | | |
| UF Health Shands Transplant | | |
| | | |
| Vantive is a vital organ therapy company on a mission to extend lives and expand possibilities for patients and care teams globally. We are focused on elevating the dialysis experience through digital solutions and advanced services, while looking beyond kidney care and investing in transforming vital organ therapies. |
|
 |
| |
|
|
| Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. | |  |
Florida Women in Nephrology Chair
FSN President
Print Page